IL1A and infection: It may also help investigate how persistent SARS‐CoV‐2‐induced inflammation affects secondary infections such as respiratory syncytial virus (RSV), where we recently reported exacerbated disease upon pre‐existing increased expression of IL‐1α and TNF‐α [49].